Abstract
Our understanding of Lyme disease relies primarily on clinical observations. The diagnosis is typically made with clinical criteria, and the effectiveness of antibiotic therapy is determined by clinical end points. Although this approach has served both patients and physicians well, important questions persist that cannot be answered by the clinical approach alone. For instance, if previously established clinical criteria are required for the diagnosis, how can atypical syndromes be evaluated as possibly due to Lyme disease? Attempts to define both the full clinical spectrum of Lyme disease and the means of accurately diagnosing the illness according to clinical criteria set…
| Original language | English (US) |
|---|---|
| Pages (from-to) | 282-283 |
| Number of pages | 2 |
| Journal | New England Journal of Medicine |
| Volume | 330 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jan 27 1994 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Lyme Disease – Where's the Bug? / Rahn, Daniel Wallace.
In: New England Journal of Medicine, Vol. 330, No. 4, 27.01.1994, p. 282-283.Research output: Contribution to journal › Editorial
}
TY - JOUR
T1 - Lyme Disease – Where's the Bug?
AU - Rahn, Daniel Wallace
PY - 1994/1/27
Y1 - 1994/1/27
N2 - Our understanding of Lyme disease relies primarily on clinical observations. The diagnosis is typically made with clinical criteria, and the effectiveness of antibiotic therapy is determined by clinical end points. Although this approach has served both patients and physicians well, important questions persist that cannot be answered by the clinical approach alone. For instance, if previously established clinical criteria are required for the diagnosis, how can atypical syndromes be evaluated as possibly due to Lyme disease? Attempts to define both the full clinical spectrum of Lyme disease and the means of accurately diagnosing the illness according to clinical criteria set…
AB - Our understanding of Lyme disease relies primarily on clinical observations. The diagnosis is typically made with clinical criteria, and the effectiveness of antibiotic therapy is determined by clinical end points. Although this approach has served both patients and physicians well, important questions persist that cannot be answered by the clinical approach alone. For instance, if previously established clinical criteria are required for the diagnosis, how can atypical syndromes be evaluated as possibly due to Lyme disease? Attempts to define both the full clinical spectrum of Lyme disease and the means of accurately diagnosing the illness according to clinical criteria set…
UR - http://www.scopus.com/inward/record.url?scp=0028144578&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028144578&partnerID=8YFLogxK
U2 - 10.1056/NEJM199401273300409
DO - 10.1056/NEJM199401273300409
M3 - Editorial
VL - 330
SP - 282
EP - 283
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 4
ER -